The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Clinical trial NCT05819060 · UNKNOWN

Trial details

NCT number: NCT05819060
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer

Start date: 2023-04-30
Primary completion: 2024-09-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.